Xtant Medical Holdings
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
-6521.66
Price/Sales ratio
0.420.34
Earnings per Share (EPS)
$-0.01$0.03

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.88-12.82-0.35-0.19-0.26-2.56-4.85-8.18-7.31203.90-10.35-2.56
Price/Sales ratio
0.560.460.070.120.260.320.630.861.071.471.520.26
Price/Book Value ratio
-2.553.14-0.98-0.17-0.43-0.472.341.541.812.621.90K-0.43
Price/Cash Flow ratio
-2.70-3.06-0.48-19.0615.59-50.99-46.63109.01-11.62-14.14-12.17-50.99
Price/Free Cash Flow ratio
-2.60-2.45-0.34-4.7432.14-16.30-14.97-28.55-8.73-12.26-9.14-9.14
Price/Earnings Growth ratio
0.050.14-0.00-0.000.000.020.080.11-0.22-1.920.130.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
63.10%65.85%69.21%60.64%60.22%65.73%64.48%58.79%55.43%60.75%55.81%65.73%
Operating Profit Margin
-17.73%-20.35%-8.38%-45.79%-83.20%-3.63%-1.40%-6.97%-11.65%-11.12%-11.78%-83.20%
Pretax Profit Margin
-29.74%-33.21%-21.60%-63.44%-97.08%-12.55%-12.61%-8.77%-14.51%-1.13%-14.58%-97.08%
Net Profit Margin
-29.74%-3.66%-21.65%-63.44%-97.08%-12.70%-13.16%-10.57%-14.63%0.72%-14.69%-97.08%
Effective Tax Rate
-50.83%88.96%-0.25%-27.91%-0.17%-1.20%-4.40%-20.51%-0.81%163.64%-0.78%-0.78%
Return on Assets
-37.59%-1.51%-13.52%-49.58%-151.00%-19.04%-16.93%-10.68%-14.08%0.71%-10423.89%-19.04%
Return On Equity
135.15%-24.49%275.59%89.28%160.14%18.59%-48.38%-18.92%-24.83%1.28%-27.83%18.59%
Return on Capital Employed
-32.17%-9.93%-6.67%-47.35%-174.79%-6.97%-4.74%-8.83%-15.00%-14.59%-11181.09%-6.97%
Liquidity Ratios
Current Ratio
2.252.111.571.532.873.431.22N/AN/AN/A3.242.87
Quick Ratio
1.121.050.730.661.441.710.382.382.101.212.041.44
Cash ratio
0.520.290.080.110.560.550.091.641.330.241.330.56
Days of Sales Outstanding
45.7394.6277.0256.1750.5057.1247.0847.2568.3382.870.0957.12
Days of Inventory outstanding
267.67408.62345.98249.55219.89265.12412.45287.61244.23375.680.33265.12
Operating Cycle
313.40503.25423.00305.73270.40322.25459.53334.86312.56458.560.35322.25
Days of Payables Outstanding
108.56169.08137.93104.5982.1736.0244.1041.9149.3171.840.0636.02
Cash Conversion Cycle
204.84334.17285.06201.14188.22286.23415.43292.95263.25386.710.10286.23
Debt Ratios
Debt Ratio
0.740.770.901.301.681.770.410.290.260.240.431.77
Debt Equity Ratio
-2.6912.47-18.36-2.35-1.79-1.731.180.510.460.440.76-1.79
Long-term Debt to Capitalization
1.590.921.061.742.282.37N/A0.270.220.250.242.37
Total Debt to Capitalization
1.590.921.051.732.262.350.540.330.310.300.332.35
Interest Coverage Ratio
-0.94-1.19-0.50-0.92-0.72-0.39-0.12N/AN/AN/A-4.20-0.39
Cash Flow to Debt Ratio
-0.35-0.08-0.11-0.000.01-0.00-0.040.02-0.33-0.41-313.99-0.00
Company Equity Multiplier
-3.5916.11-20.37-1.80-1.06-0.972.851.771.761.801.76-1.06
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.20-0.15-0.16-0.000.01-0.00-0.010.00-0.09-0.10-0.12-0.00
Free Cash Flow / Operating Cash Flow Ratio
1.041.241.404.020.483.123.11-3.811.331.151.330.48
Cash Flow Coverage Ratio
-0.35-0.08-0.11-0.000.01-0.00-0.040.02-0.33-0.41-313.99-0.00
Short Term Coverage Ratio
-144.54-258.96-1.34-1.482.84-0.72-0.040.10-0.85-1.72-865.64-0.72
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A